BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34940078)

  • 21. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
    Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
    Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.
    Brennan C; Yang TJ; Hilden P; Zhang Z; Chan K; Yamada Y; Chan TA; Lymberis SC; Narayana A; Tabar V; Gutin PH; Ballangrud Å; Lis E; Beal K
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):130-6. PubMed ID: 24331659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
    Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes for Pituitary Adenoma Patients Treated with Linac- Based Stereotactic Radiosurgery and Radiotherapy: a Long Term Experience in Thailand.
    Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Swangsilpa T; Vitoonpanich P; Yongvithisatid P
    Asian Pac J Cancer Prev; 2015; 16(13):5279-84. PubMed ID: 26225666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
    Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
    Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases.
    Rades D; Witteler J; Kjaer TW; Tvilsted S; Schild SE
    Anticancer Res; 2020 Jun; 40(6):3499-3504. PubMed ID: 32487650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases.
    Perlow HK; Ho C; Matsui JK; Prasad RN; Klamer BG; Wang J; Damante M; Upadhyay R; Thomas E; Blakaj DM; Beyer S; Lonser R; Hardesty D; Raval RR; Prabhu R; Elder JB; Palmer JD
    Clin Transl Radiat Oncol; 2023 Jan; 38():117-122. PubMed ID: 36420099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
    Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
    Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients.
    Deguchi S; Mitsuya K; Yasui K; Kimura K; Onoe T; Ogawa H; Asakura H; Harada H; Hayashi N
    Int J Clin Oncol; 2022 Mar; 27(3):481-487. PubMed ID: 34796412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis.
    Balducci M; Autorino R; Chiesa S; Mattiucci G; Pompucci A; Azario L; D'Agostino GR; Ferro M; Fiorentino A; Fersino S; Mazzarella C; Colosimo C; Frascino V; Anile C; Valentini V
    Anticancer Res; 2015 May; 35(5):3055-9. PubMed ID: 25964595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
    Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
    J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain Metastasis.
    Matsuda R; Hasegawa M; Tamamoto T; Inooka N; Nikimoto M; Ochi T; Miyasaka T; Hontsu S; Yamaki K; Miura S; Morimoto T; Mitsui T; Furuta T; Yokoyama S; Kotsugi M; Yamada S; Nakagawa I; Park YS; Nakase H
    Curr Oncol; 2022 Aug; 29(9):6068-6076. PubMed ID: 36135046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Gamma Knife (GK) and Linear Accelerator (LINAC) radiosurgery of brain metastasis resection cavity: a systematic review and proportional meta-analysis.
    Dharnipragada R; Dusenbery K; Watanabe Y; Ferreira C; Chen CC
    Clin Exp Metastasis; 2024 Feb; 41(1):1-8. PubMed ID: 37943360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.